QLOSI Drug Patent Profile

✉ Email this page to a colleague

When do Qlosi patents expire, and what generic alternatives are available?

Qlosi is a drug marketed by Orasis Pharms and is included in one NDA. There are three patents protecting this drug.

This drug has twenty-three patent family members in fourteen countries.

The generic ingredient in QLOSI is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Qlosi

A generic version of QLOSI was approved as pilocarpine hydrochloride by PADAGIS US on November 16^th, 2004.

Try a Trial

Summary for QLOSI

International Patents:	23
US Patents:	3
Applicants:	1
NDAs:	1
Formulation / Manufacturing:	see details
DailyMed Link:	QLOSI at DailyMed

Drug patent expirations by year for QLOSI

Anatomical Therapeutic Chemical (ATC) Classes for QLOSI

N07AX	Other parasympathomimetics
N07A	PARASYMPATHOMIMETICS
N07	OTHER NERVOUS SYSTEM DRUGS
N	Nervous system

S01EB	Parasympathomimetics
S01E	ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for QLOSI

QLOSI is protected by three US patents and one FDA Regulatory Exclusivity.

Patents protecting QLOSI

Ophthalmic pharmaceutical compositions and uses relating thereto
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF PRESBYOPIA

FDA Regulatory Exclusivity protecting QLOSI

NEW PRODUCT
Exclusivity Expiration: ⤷ Try a Trial

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Orasis Pharms	QLOSI	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	217836-001	Oct 17, 2023		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Orasis Pharms	QLOSI	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	217836-001	Oct 17, 2023		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Orasis Pharms	QLOSI	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	217836-001	Oct 17, 2023		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Orasis Pharms	QLOSI	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	217836-001	Oct 17, 2023		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for QLOSI

See the table below for patents covering QLOSI around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Spain	2934790		⤷ Try a Trial
China	109803652	眼科药物组合物及其相关用途 (OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES RELATING THERETO)	⤷ Try a Trial
Brazil	112019002967	composição farmacêutica oftálmica, métodos de corrigir presbiopia, de reduzir o tamanho de uma pupila, de induzir miose, de aumentar a profundidade de campo, de diminuir a grandeza de aberrações de ordem superior e de melhorar a acuidade visual não corrigida de perto e de longe, implante, e, kit.	⤷ Try a Trial
South Korea	102472774		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for QLOSI

Anatomical Therapeutic Chemical (ATC) Classes for QLOSI

Patents protecting QLOSI

FDA Regulatory Exclusivity protecting QLOSI

Make Better Decisions: Try a trial or see plans & pricing